These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4439778)

  • 1. [Results of treatment of patients with serous cystoadenocarcinoma of the ovaries].
    Sitnikova GP
    Vopr Onkol; 1974; 20(11):67-72. PubMed ID: 4439778
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of the dissemination process in patients with serous cystadenocarcinoma of the ovaries].
    Dzhilavian GA
    Vopr Onkol; 1984; 30(8):83-6. PubMed ID: 6485289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immediate and late results of treating serous cystadeno-carcinoma of the ovaries with radiation therapy].
    Sitnikova GP
    Vopr Onkol; 1974; 20(4):29-34. PubMed ID: 4439811
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization and survival of patients with serous cystadenocarcinoma of the ovaries.
    Demopoulos RI; Bigelow B; Blaustein A; Chait J; Gutman E; Dubin N
    Obstet Gynecol; 1984 Oct; 64(4):557-63. PubMed ID: 6483302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
    Dzhilavian GA; Vinokurov VL
    Vopr Onkol; 1984; 30(3):16-21. PubMed ID: 6424327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer of the ovary. Survival studies based upon operative therapy, chemotherapy, and radiotherapy.
    Parker RT; Parker CH; Wilbanks GD
    Am J Obstet Gynecol; 1970 Nov; 108(6):878-88. PubMed ID: 4098756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radiotherapy of malignant ovarian tumors using 42 megavolt photons].
    Halama J; Fiebach O
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:7-8. PubMed ID: 4344611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Survival of patients with malignant tumors of the ovaries in relation to the stage according to the TNM classification].
    Kotova DG
    Vopr Onkol; 1976; 22(1):36-43. PubMed ID: 1266119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-morphological characteristics and results of treatment of endometrioid cystadenocarcinoma of the ovary].
    Vinokurov VL; Livshits MA; Tsyrlina EV; Kolosov AE
    Vopr Onkol; 1983; 29(12):49-56. PubMed ID: 6420990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy in selected ovarian cancers. A negative report.
    Hannemann JH
    Rocky Mt Med J; 1972 Feb; 69(2):57-61. PubMed ID: 4621436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immediate and remote results of surgical, chemotherapeutic,radiation, combined and complex treatment of patients with serous cystadenocarcinoma of the ovaries].
    Nechaeva ID; Kotova DG; Vinokurov VL; Livshits MA; Semenovskiĭ AV
    Vopr Onkol; 1976; 22(11):68-74. PubMed ID: 1014505
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of ovarian carcinoma--a review of 420 cases.
    Barr W; Cowell AC; Chatfield WR
    Scott Med J; 1970 Jul; 15(7):250-6. PubMed ID: 5427786
    [No Abstract]   [Full Text] [Related]  

  • 13. [Whole abdominal irradiation of ovarian cancer in combined treatment with OK-432 picibanil].
    Morita S; Arai T; Tsunemoto H
    Gan No Rinsho; 1986 Jan; 32(1):71-5. PubMed ID: 3005691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer: epidemiology, diagnosis, and management.
    Blayney DW; Longo DL
    Compr Ther; 1983 Jan; 9(1):50-8. PubMed ID: 6831853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor influencing survival in Stage I ovarian cancer.
    Webb MJ; Decker DG; Mussey E; Williams TJ
    Am J Obstet Gynecol; 1973 May; 116(2):222-8. PubMed ID: 4704002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of serous adenocarcinoma of the ovary by a protocol consisting of 1st surgery, polychemotherapy with cisplatin as base, surgical reoperation for control, and radiotherapy and/or maintenance chemotherapy. Study of a series of 56 cases. Thoughts and prospects].
    Clavel B; Delouche G; Harvey P; Berlie J; Laval C; Tubiana-Hulin M; Lemoine F
    Ann Chir; 1984 Jun; 38(5):337-47. PubMed ID: 6541016
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of a method of chemosurgical treatment of malignant ovarian tumors].
    Nechaeva ID; Kotova DG; Vinokurov VL; Loskutova GP; Livshits MA
    Vopr Onkol; 1980; 26(3):33-6. PubMed ID: 7368654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy in malignant disease of the ovary.
    Dalley VM
    Proc R Soc Med; 1969 Apr; 62(4):359-61. PubMed ID: 4980487
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of preoperative chemotherapy on the DNA content in ovarian serous cystadenocarcinomas].
    Irzhanov SI; Serov SF
    Vopr Onkol; 1981; 27(8):49-52. PubMed ID: 6792783
    [No Abstract]   [Full Text] [Related]  

  • 20. The evaluation of postoperative irradiation in patients with early-stage ovarian cancer.
    Leers WH; Kock HC
    Gynecol Oncol; 1987 Sep; 28(1):41-9. PubMed ID: 3653769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.